PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsPilocarpine
Pilocarpine
Isopto Carpine, Pilo, Qlosi, Salagen, Vuity (pilocarpine) is a small molecule pharmaceutical. Pilocarpine was first approved as Ocusert pilo-20 on 1982-01-01. It is used to treat angle-closure glaucoma, head and neck neoplasms, mydriasis, and xerostomia in the USA. The pharmaceutical is active against muscarinic acetylcholine receptor M3. In addition, it is known to target muscarinic acetylcholine receptor M2, muscarinic acetylcholine receptor M5, muscarinic acetylcholine receptor M1, and muscarinic acetylcholine receptor M4.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
neoplasmsD009369
stomatognathic diseasesD009057
eye diseasesD005128
Trade Name
FDA
EMA
Isopto carpine, Pilocarpine, Salagen, Vuity (discontinued: Ocusert pilo, Pilopine hs)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Pilocarpine hydrochloride
Tradename
Company
Number
Date
Products
VUITYAbbVieN-214028 RX2021-10-28
1 products, RLD, RS
SALAGENConcordia LaboratoriesN-020237 RX1994-03-22
2 products, RLD
ISOPTO CARPINESandozN-200890 RX2010-06-22
3 products, RLD, RS
Show 1 discontinued
Pilocarpine
Tradename
Company
Number
Date
Products
OCUSERT PILO-20Epic PharmaN-017431 DISCN1982-01-01
1 products
OCUSERT PILO-40Epic PharmaN-017548 DISCN1982-01-01
1 products
Hide discontinued
Betaxolol hydrochloride
+
Pilocarpine hydrochloride
Tradename
Company
Number
Date
Products
BETOPTIC PILOAlcon ResearchN-020619 DISCN1997-04-17
1 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
betoptic pilo2006-06-19
pilocarpineunapproved drug other2011-12-02
pilocarpine hydrchlorideANDA2024-05-31
pilocarpine hydrochlorideANDA2024-07-15
qlosiNew Drug Application2024-06-24
salagenNew Drug Application2022-02-11
vuityNew Drug Application2023-03-28
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
head and neck neoplasms—D006258—
xerostomia—D014987K11.7
angle-closure glaucoma—D015812—
mydriasisHP_0011499D015878H57.04
hypertensionEFO_0000537D006973I10
open-angle glaucomaEFO_0004190D005902H40.1
Agency Specific
FDA
EMA
Expiration
Code
PILOCARPINE HYDROCHLORIDE, VUITY, ABBVIE
2026-03-28D-187
2024-10-28NP
Patent Expiration
Patent
Expires
Flag
FDA Information
Pilocarpine Hydrochloride, Vuity, Abbvie
106105182039-04-24U-3252, U-3561, U-3562
112851342039-04-24U-3252, U-3561, U-3562
ATC Codes
N: Nervous system drugs
— N07: Other nervous system drugs in atc
— N07A: Parasympathomimetics
— N07AX: Other parasympathomimetics in atc
— N07AX01: Pilocarpine
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01E: Antiglaucoma preparations and miotics
— S01EB: Parasympathomimetics, antiglaucoma preparations and miotics
— S01EB01: Pilocarpine
— S01EB51: Pilocarpine, combinations
HCPCS
No data
Clinical
Clinical Trials
70 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
GlaucomaD005901EFO_0000516H40——32813
XerostomiaD014987—K11.71132612
Open-angle glaucomaD005902EFO_0004190H40.1——1157
Angle-closure glaucomaD015812—————123
Sjogren's syndromeD012859EFO_0000699M35.0——11—2
AnisocoriaD015875—H57.02———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PresbyopiaD011305—H52.45311—120
Ocular hypertensionD009798EFO_1001069H40.0——2—57
Exfoliation syndromeD017889EFO_0004235———1—34
HypertensionD006973EFO_0000537I10——1—23
Head and neck neoplasmsD006258———13——3
PseudophakiaD019591——1—1——2
CataractD002386HP_0000518H26.9——1—12
Keratoconjunctivitis siccaD007638EFO_1000906——11——2
Dry eye syndromesD015352—H04.12—11——2
Overactive urinary bladderD053201EFO_1000781N32.81——1——1
Show 4 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
MyopiaD009216EFO_0003927H52.111——12
HyperopiaD006956EFO_0006310H52.011———1
KeratoconjunctivitisD007637—H16.2—1———1
Eye diseasesD005128EFO_0003966H44—1———1
ConjunctivitisD003231HP_0000509H10—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———2————2
Urinary incontinenceD014549HP_0000020R321————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Cystic fibrosisD003550EFO_0000390E84————33
SyndromeD013577——————22
KeratoconusD007640EFO_0004223H18.6————22
Diabetes mellitusD003920HP_0000819E08-E13————11
FibrosisD005355——————11
InfectionsD007239EFO_0000544—————11
Communicable diseasesD003141——————11
Staphylococcal infectionsD013203—A49.01————11
Chronic kidney failureD007676EFO_0003884N18.9————11
Postoperative cognitive complicationsD000079690——————11
Show 5 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common namePilocarpine
INN—
Description
(+)-pilocarpine is the (+)-enantiomer of pilocarpine. It has a role as an antiglaucoma drug. It is an enantiomer of a (-)-pilocarpine.
Classification
Small molecule
Drug classtricyclic compounds
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CC[C@@H]1C(=O)OC[C@@H]1Cc1cncn1C
Identifiers
PDB—
CAS-ID92-13-7
RxCUI—
ChEMBL IDCHEMBL550
ChEBI ID8207
PubChem CID5910
DrugBankDB01085
UNII ID—
Target
Agency Approved
No data
Alternate
CYP2A6
CYP2A6
Organism
Homo sapiens
Gene name
CYP2A6
Gene synonyms
CYP2A3
NCBI Gene ID
1548
Protein name
cytochrome P450 2A6
Protein synonyms
1,4-cineole 2-exo-monooxygenase, Coumarin 7-hydroxylase, CYPIIA6, Cytochrome P450 IIA3, Cytochrome P450(I), cytochrome P450, family 2, subfamily A, polypeptide 6, cytochrome P450, subfamily IIA (phenobarbital-inducible), polypeptide 6, flavoprotein-linked monooxygenase, xenobiotic monooxygenase
Uniprot ID
Q9UK48
Mouse ortholog
—
—
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
No data
Estimated US medical usage
Pilocarpine
+
Epinephrine
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Pilocarpine
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 19,973 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
2,011 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use